Monitoring the Prevalence of Antimicrobial Resistance in Companion Animals: Results from Clinical Isolates in an Italian University Veterinary Hospital
Table 6
Nonsusceptibility percentages for every single tested drug considering only the 169 isolates identified as bacterial species belonging to the ESKAPE group, isolated from cats and dogs referred to a University Veterinary Hospital between September 2020 and November 2022.
E. faecium
S. aureus
K. pneumoniae
A. baumannii
P. aeruginosa
Enterobacter spp.
Amikacin
Nt
6.67% (1/15)
8.51% (4/47)
0% (0/2)
11.11% (5/45)
9.52% (4/42)
Gentamicin
33.33% (6/18)
20.00% (3/15)
27.66% (13/47)
50.00% (1/2)
17.78% (8/45)
16.67% (7/42)
Ampicillin
83.33% (15/18)
86.67% (13/15)
Nt
Nt
Nt
Nt
Amoxicillin–clavulanate
83.33% (15/18)
26.67% (4/15)
48.94% (23/47)
Nt
Nt
Nt
Piperacillin–tazobactam
77.78% (14/18)
20.00% (3/15)
48.94% (23/47)
50.00% (1/2)
4.44% (2/45)
42.86% (18/42)
Cefazolin/cephalotin
Nt
33.33% (5/15)
65.96% (31/47)
Nt
Nt
Nt
Ceftiofur
Nt
40.00% (6/15)
61.70% (29/47)
Nt
Nt
47.62% (20/42)
Tetracycline
88.89% (16/18)
46.67% (7/15)
51.06% (24/47)
100.00% (1/1)
93.33% (42/45)
30.95% (13/42)
Erythromycin
Nt
33.33% (5/15)
Nt
Nt
Nt
Nt
Clindamycin
Nt
13.33% (2/15)
Nt
Nt
Nt
Nt
Enrofloxacin
100.00% (18/18)
46.67% (7/15)
70.21% (33/47)
50.00% (1/2)
86.67% (39/45)
59.52% (25/42)
Trimethoprim–sulfamethoxazole
44.44% (8/18)
6.67% (1/15)
53.19% (25/47)
100.00% (1/1)
Nt
47.62% (20/42)
Note: Nt stands for “non tested” due to intrinsic resistance. For each bacterial species, the total number of nonsusceptible isolates out of the total number of total isolates is reported in brackets.
